Nicole Shonka, MD

Nicole Shonka, MDShonkaPP
Associate Professor, Internal Medicine
Division of Oncology & Hematology

Academic Office mailing address:
UNMC Oncology/Hematology Division
986840 Nebraska Medical Center
Omaha, NE 68198-6840

Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600

Practice locations:
Fred & Pamela Buffett Cancer Center
505 S. 45th Street
Omaha, NE 68105 (map)

Cancer Center at Village Pointe
111 North 175th Street
Omaha, NE 68118 (map)

University of Nebraska Medical Center, Resident, (2002-2005)
University of Nebraska Medical Center, Fellow, (2007-2009)
University of Texas MD Anderson Cancer Center, Fellow (2009-2010)

Hospital Appointments:
Nebraska Medicine

Research in novel therapies for primary tumors of the brain and spine, secondary brain tumors, and leptomeningeal disease

Biographical Sketch:
Dr. Nicole Shonka is an Associate Professor in the Oncology/Hematology Division in the Department of Internal Medicine at UNMC. Dr. Shonka received her medical education at UNMC and did her residency and general oncology fellowship at UNMC as well. She then went to the University of Texas' MD Anderson Cancer Center where she completed an additional Neuro-oncology fellowship and returned to Nebraska as faculty in July 2010. She is currently the only fellowship-trained Neuro-oncologist in the state of Nebraska.

She has developed a CNS tumors web-based registry to aid future translational research, and has been recognized at the national and international level in Neuro-oncology, serving on the National Comprehensive Cancer Network’s guidelines committee for CNS malignancies, and was an invited member of ASCO’s Cancer Education Committee on the Central Nervous System Tumors Track from 2015-2018.

She is involved in clinical and translational research in gliomas, and has had investigator-initiated projects using biomarkers in glioblastoma, combining high dose IV vitamin C with chemotherapeutic agents for high-grade glioma, and novel drug testing on a unique mouse model of glioblastoma.  She serves as the PI for many clinical trials, including prior phase I investigator-initiated studies, pharmaceutical sponsored studies, and cooperative group trials.


Publications at PubMed.Gov: